These results establish the importance of adaptive immunity and CD1d-restricted NKT cells in preventing metastatic cancer progression of CD1d-expressing tumors, but do not directly implicate the importance of type I NKT cells in this model. This evidence concerns the gene CD1D and metastatic malignant neoplasm.